Premier Heart to Exhibit its Multifunction CardioGram (MCGâ„¢) at American College of Cardiology in New Orleans April 2-5
PORT WASHINGTON, N.Y., March 30, 2011 /PRNewswire/ -- Premier Heart, LLC is proud to be exhibiting the Multifunction CardioGram at ACC 11, the 60th Annual Scientific Sessions and Expo of the American College of Cardiology to be held April 2-5, 2011 in New Orleans. The MCG offers completely non-invasive cardiac testing using "power estimate as an aid to assist physicians in diagnosis" according to its latest US FDA 510K Clearance. MCG is a chemical and radiation-free procedure, the performance of which has been shown in published clinical trials to be associated with little risk of adverse events to the patient.
According to Dr. Joseph T. Shen, founder of Premier Heart and the lead developer of Premier Heart's Multifunction CardioGram, "Using a computational systems analysis approach we, as physicians, now have a method that analyzes and compares raw electro-cardiac data to help identify significant CAD and which has been shown in multiple studies to assist in accurate detection the presence of significant coronary artery disease requiring intervention with improved specificity and negative predictive values. MCG's advanced technology works by sampling a signal from two left ventricular leads (V5 and II) and performing a series of digital signal analysis operations. The operations produce a sequence of indexes, which quantify abnormalities in the mathematically transformed electro-cardiac data. This information is transferred via the Internet to Premier Heart in New York, where it is compared to a database of over 40,000 patients. A numeric score is assigned based on this analysis representing the likelihood and severity of CAD. This score is reported back to physicians within minutes to aid in detection and diagnosis in a point of care setting."
Premier Heart's MCG is being used by many physicians in the